ROBINS CHAD M sold ADPT

August 18, 2026 · Form 4 insider transaction

ROBINS CHAD M sold 278,472 shares of Adaptive Biotechnologies Corporation at $24.48 per share, a transaction worth $6.82M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
278,472
Price
$24.48
Total value
$6.82M
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 18, 2026
Filing dateAugust 19, 2026
Shares owned after2,180,722
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The price reported for this transaction is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.12 to $25.12, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.

View the original Form 4 on SEC EDGAR